Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Ángel Crespo López, Robert F. Grover, Jan Bakker et al.|Critical Care Medicine|2004Cited by 921
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007Tara Lagu, Peter K. Lindenauer, Michael B. Rothberg et al.|Critical Care Medicine|2011Cited by 675
Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung InjuryKathleen D. Liu, Michael A. Matthay, Joseph E. Levitt et al.|American Journal of Respiratory and Critical Care Medicine|2008Cited by 210
Epidemiology and outcomes of acute respiratory failure in the <scp>U</scp>nited <scp>States</scp>, 2001 to 2009: A national surveyMihaela Stefan, Peter K. Lindenauer, Meng‐Shiou Shieh et al.|Journal of Hospital Medicine|2013Cited by 184
Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome*Angela J. Rogers, Rebecca M. Baron, Jiazhen Guan et al.|Critical Care Medicine|2019Cited by 93